Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-15 Purchase |
2022-03-17 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
12,000 | $8.39 | $100,680 | 12,000 (Direct) |
View |
| 2022-03-14 Purchase |
2022-03-16 4:46 pm |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
10,000 | $8.1934 | $81,934 | 20,000 (Indirect) |
View |
| 2022-01-04 Purchase |
2022-01-06 4:06 pm |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
10,000 | $16.36 | $163,650 | 10,000 (Indirect) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:59 pm |
BridgeBio Pharma Inc. | BBIO | SAUNDERS BRENT L Director |
17,600 | $14.48 | $254,880 | 17,600 (Direct) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:57 pm |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
7,500 | $13.18 | $98,850 | 253,682 (Indirect Direct) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:53 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
1,764 | $14.23 | $25,102 | 1,764 (Direct) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:50 pm |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
19,300 | $14.17 | $273,390 | 19,300 (Direct) |
View |
| 2021-12-29 Purchase |
2022-01-03 7:47 pm |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
80,000 | $14.5 | $1,160,000 | 88,491 (Direct) |
View |
| 2021-12-28 Purchase |
2021-12-30 8:17 pm |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
22,147 | $13.49 | $298,679 | 10,402 (Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 8:17 pm |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
11,745 | $12.8 | $150,336 | 10,402 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | SAUNDERS BRENT L Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:34 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:30 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:29 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:28 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:27 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:26 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:25 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:23 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director |
104,921 | $0 | 104,921 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 4:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
1,310 | $6.74 | 70,116 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:09 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
3,195 | $0 | 70,116 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
23,759 | $6.74 | 8,076,242 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
137,410 | $0 | 8,076,242 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
9,228 | $6.74 | 515,395 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
53,360 | $0 | 515,395 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
1,541 | $6.74 | 1,233,301 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
3,759 | $0 | 1,233,301 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:26 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
489,456 | $0 | 489,456 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:24 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
193,543 | $0 | 193,543 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-15 5:37 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
25,566 | $0 | 25,566 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-15 5:34 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
30,078 | $0 | 30,078 (Direct) |
View |
| 2022-02-16 Exercise |
2022-02-18 4:35 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
15,048 | $0 | 7,610,545 (Direct) |
View |
| 2022-02-16 Tax Withholding |
2022-02-18 4:35 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
3,085 | $8.84 | 7,610,545 (Direct) |
View |
| 2022-02-16 Exercise |
2022-02-18 4:35 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
4,976 | $0 | 331,080 (Direct) |
View |
| 2022-02-16 Tax Withholding |
2022-02-18 4:35 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,020 | $8.84 | 331,080 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 6:14 pm |
N/A 2031-12-02 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
786,072 | $0 | 786,072 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 6:05 pm |
N/A 2031-12-02 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
226,510 | $0 | 226,510 (Direct) |
View |
| 2021-12-02 Option Award |
2021-12-06 8:58 pm |
2022-12-02 2031-12-01 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
55,011 | $0 | 55,011 (Direct) |
View |
| 2021-12-02 Option Award |
2021-12-06 8:55 pm |
2022-12-02 2031-12-01 |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director |
45,566 | $0 | 45,566 (Direct) |
View |
| 2021-11-16 Tax Withholding |
2021-11-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
3,730 | $47.25 | 7,613,630 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
15,046 | $0 | 7,613,630 (Direct) |
View |
| 2021-11-16 Tax Withholding |
2021-11-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,234 | $47.25 | 331,595 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
4,976 | $0 | 331,595 (Direct) |
View |
| 2021-10-25 Option Award |
2021-10-26 9:16 pm |
N/A 2031-10-24 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
50,968 | $0 | 50,968 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-26 5:15 pm |
N/A 2031-08-16 |
BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director |
49,869 | $0 | 49,869 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-26 5:14 pm |
N/A 2031-08-16 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
49,869 | $0 | 49,869 (Direct) |
View |